Pavilion Health Today

Supporting healthcare professionals to deliver the best patient care

Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM

Tel: +44 (0)1273 434 943

Email: [email protected]

Advances in the management of age-related macular degeneration

Age-related macular degeneration (AMD) is a progressive disorder of the retina in older adults. DryAMD, characterised by deposits in the fundus, does not cause significant vision loss. But if it progressesto advanced AMD, it can cause severe vision loss if left untreated. Laser therapy, which itself candamage the retina, was standard therapy during 1980 and 90s. However, a class of drugs that inhibitvascular endothelial growth factor has revolutionised outcomes for many patients

By admin On 28 Jan 2013 Last updated 6 Oct 2022

Age-related macular degeneration (AMD) is a progressive disorder of the retina in older adults. DryAMD, characterised by deposits in the fundus, does not cause significant vision loss. But if it progressesto advanced AMD, it can cause severe vision loss if left untreated. Laser therapy, which itself candamage the retina, was standard therapy during 1980 and 90s. However, a class of drugs that inhibitvascular endothelial growth factor has revolutionised outcomes for many patients.